2025-522930-29-00招募中1 期
A Trial to Examine the Effects of MSP-2020 on Brain Activity in Healthy Adults
Otsuka Pharmaceutical Development & Commercialization Inc.1 个研究点 分布在 1 个国家目标入组 72 人开始时间: 2025年10月31日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 72
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 64 years（18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Dalton Hughes
Scientific
Otsuka Pharmaceutical Development & Commercialization Inc.
研究点 (1)
Loading locations...
相似试验
已完成
1 期
A Phase 1 Randomized Study to Evaluate the Effect of Food on the Bioavailability of BMS-986158 in Participants with Advanced Solid Tumors.2023-506661-65-00Bristol-Myers Squibb Services Unlimited Company40
招募中
2 期
LAMSA2020: “A phase II randomized study to assess the efficacy on outcome of Venetoclax combined with Cytarabine versus Idarubicin combined with Cytarabine administered as post-remission therapy to elderly patients with acute myeloid leukemia in first remission”2022-502392-37-00French Innovative Leukemia Organization114
尚未招募
3 期
MHB018A Treatment in Patients With Chronic Thyroid Eye DiseaseNCT07257185Minghui Pharmaceutical (Hangzhou) Ltd150
尚未招募
3 期
Open-Label Extension Study of MHB018A in Subjects With Thyroid Eye DiseaseNCT07262476Minghui Pharmaceutical (Hangzhou) Ltd258
招募中
4 期
A Phase I double blinded, single-center, randomized, crossover study comparing the PK, PD, safety and tolerability of a single IV dose (1µg/kg) of LB-0702 and Nplate® in healthy volunteers.2024-518285-27-00Laboratorio Reig Jofre S.A.34